F-star is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies with the goal of creating a paradigm-shift in cancer therapy F-star is a biopharmaceutical company focused on developing immuno-oncology bispecific antibody therapeutics. We are committed to delivering life-changing treatments to those patients with cancer who are not well-served by current therapies through the application of our Modular Antibody Technology™ platform.
Phone: 44-1223-497400
E-mail: cambridge@f-star.com
Web: http://www.f-star.com
Add：Eddeva B920, Babraham Research Campus, Cambridge, CB22 3AT, UK
想要下载更多资料，请您添加微信了解详情！
微信号：csco2022
公众号：康安医药咨询
